8 March 2022 - trading update
The AIM-listed infection protection company has issued a trading update covering the second half of its financial year to 31 March 2022 and this has revealed a significant increase in product sales over the first half. Product sales for the year should be around £5.2m which will be below the figure reported for the year to 31 March 2021 although of course that year benefited from bumper demand due to the pandemic. The improved sales together with IP sales either agreed or expected to be agreed for the second half mean that the . . .
This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.
Already a member, log in HERE.
